Phaco Centrum Oogkliniek is Clinics/Outpatient Services in Netherlands that focus on ophthalmological treatments business. Founded in 2008. They cover business area such as operator, an eye clinic, various ophthalmological treatment, modern equipment, the-art, patient, cataract, macular degeneration, glaucoma, retinal abnormality, diabetes.
2008
( 16 years old in 2024 )
Ophthalmological Treatments
-
Vughterweg 47 K
5211 CK 's-Hertogenbosch
Netherlands
Private
operatoran eye clinicvarious ophthalmological treatmentmodern equipmentthe-artpatientcataractmacular degenerationglaucomaretinal abnormalitydiabetes
* We use standard office opening hours in near Phaco Centrum Oogkliniek's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Phaco Centrum Oogkliniek is Clinics/Outpatient Services business from Netherlands that founded in 2008 (16 years old in 2024), Phaco Centrum Oogkliniek business is focusing on Ophthalmological Treatments.
Phaco Centrum Oogkliniek headquarter office and corporate office address is located in Vughterweg 47 K 5211 CK 's-Hertogenbosch Netherlands.
Phaco Centrum Oogkliniek was founded in Netherlands.
In 2024, Phaco Centrum Oogkliniek is currently focus on ophthalmological treatments sector.
Above is snippet of Google Trends for "ophthalmological treatments" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Phaco Centrum Oogkliniek, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.